{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:30:00Z","timestamp":1782127800479,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jbspin.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T08:32:45Z","timestamp":1481790765000},"page":"563-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of triple association methotrexate, sulfasalazine and hydroxychloroquine in early treatment of rheumatoid arthritis with insufficient response to methotrexate: Meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"84","author":[{"given":"Arnaud","family":"Mazouy\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athan","family":"Baillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2016.10.010_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbspin.2011.04.008","article-title":"Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI","volume":"79","author":"Gaujoux-Viala","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0155","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/ard.2007.076299","article-title":"Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis","volume":"67","author":"Choy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0160","first-page":"2097","article-title":"Importance of psychological well being and disease activity in termination of an initial DMARD therapy","volume":"24","author":"Listing","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0165","first-page":"1323","article-title":"Treatment of rheumatoid arthritis with methotrexate: a prospective open long-term study of 191 cases","volume":"18","author":"Sany","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/ard.2008.099861","article-title":"Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis","volume":"68","author":"Katchamart","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/annrheumdis-2011-201162","article-title":"Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial","volume":"72","author":"De Jong","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0180","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O\u2019Dell","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0185","first-page":"699","article-title":"Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis","volume":"17","author":"Calguneri","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0190","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1169-8330(11)70004-7","article-title":"Int\u00e9r\u00eat de la triple association m\u00e9thotrexate, salazopyrine et hydroxychloroquine dans la polyarthrite rhumato\u00efde\u00a0: analyse syst\u00e9matique de la litt\u00e9rature","volume":"78","author":"Baillet","year":"2011","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0200","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jbspin.2013.09.001","article-title":"Recommendations for using TNF\u03b1 antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health","volume":"80","author":"Go\u00ebb","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jbspin.2011.01.010","article-title":"Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review","volume":"78","author":"Mouterde","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(09)60944-2","article-title":"Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial","volume":"374","author":"Van Vollenhoven","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0215","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/annrheumdis-2013-203243","article-title":"A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study","volume":"73","author":"Heimans","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0225","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0230","first-page":"2304","article-title":"Method guidelines for Cochrane Musculoskeletal Group systematic reviews","volume":"33","author":"Maxwell","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0240","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/rheumatology\/38.10.941","article-title":"Reliability and sensitivity to change of a simplification of the Sharp\/van der Heijde radiological assessment in rheumatoid arthritis","volume":"38","author":"van der Heijde","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.1780380106","article-title":"Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity","volume":"38","author":"Smolen","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1303006","article-title":"Therapies for active rheumatoid arthritis after methotrexate failure","volume":"369","author":"O\u2019Dell","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0265","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(12)60027-0","article-title":"Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial","volume":"379","author":"van Vollenhoven","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0270","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/art.34498","article-title":"A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial","volume":"64","author":"Moreland","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0275","doi-asserted-by":"crossref","first-page":"h1046","DOI":"10.1136\/bmj.h1046","article-title":"Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial","volume":"350","author":"Scott","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0280","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/annrheumdis-2013-204128","article-title":"Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab","volume":"74","author":"Neovius","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0285","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/acr.22638","article-title":"Etanercept-methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritis","volume":"67","author":"Bonafede","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2016.10.010_bib0290","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/1529-0131(200010)43:10<2316::AID-ANR20>3.0.CO;2-6","article-title":"A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16302081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16302081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T20:55:04Z","timestamp":1536180904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X16302081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1297319X16302081"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.10.010","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of triple association methotrexate, sulfasalazine and hydroxychloroquine in early treatment of rheumatoid arthritis with insufficient response to methotrexate: Meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}